Atlas Trials

Effect of Arabinoxylan Oligosaccharides Consumption on Insulin Resistance in Patients With Metabolic Syndrome

Clinical trial NCT02623777 · COMPLETED

Trial details

NCT number
NCT02623777
Sponsor
KU Leuven
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Metabolic Syndrome
Start date
2015-03-01
Primary completion
2015-10-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.